UTI Q3 FY25 earnings: revenue up 15%, EPS $0.19, debt down 41%

Q: How much did UTI (NYSE:UTI) earn per share in Q3 FY25?

Diluted EPS was $0.19 , up from $0.09 in the prior-year quarter.

Q: What drove Universal Technical Institute's 15% revenue increase?

Organic enrollment gains at legacy UTI campuses and a 21% jump at Concorde contributed to the $204.3 m total.

Q: How has UTI's debt position changed since September 2024?

Total debt fell to $73.8 m from $126.1 m, a 41% reduction driven by revolver pay-downs.

Q: Why did cash balances decline sharply this quarter?

Management used cash to repay $56 m on the revolver and purchased $54.6 m of held-to-maturity bonds.

Q: Did Universal Technical Institute meet all loan covenants?

Leverage metrics were met, but the quick-ratio (0.62 vs 0.65) missed; the lender granted a waiver.

[10-Q] Universal Technical Institute, Inc. Quarterly Earnings Report

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

10-Q

Rhea-AI Filing Summary

Q3 FY25 highlights (ended 6/30/25): Revenue rose 15% YoY to $204.3 m, driven by Universal Technical Institute (UTI) +12% and Concorde +21%. Operating income nearly doubled to $14.2 m, lifting margin to 6.9% (4.2%). Net income jumped 114% to $10.7 m; diluted EPS $0.19 vs $0.09. For the nine-month period revenue grew 14% to $613.2 m and net income 91% to $44.3 m ($0.80 per diluted share).

Cash & Capital: Cash fell to $70.7 m from $161.9 m as $56 m of revolver debt was repaid and $54.6 m shifted into held-to-maturity bonds. Total debt dropped 41% to $73.8 m; leverage covenant met, but a 0.62 quick ratio (req. 0.65) needed a bank waiver. Operating cash flow improved to $40.2 m (vs $18.4 m). Share count rose to 54.4 m after full conversion of Series A preferred, eliminating $1 m of annual dividends. Book value increased 18% since FY-end to $306.8 m.

Outlook & risks: No new guidance issued. Key watch-points include Title IV regulatory exposure, integration of acquisitions, campus consolidations and maintaining adequate liquidity.

2025 須岅硠鞐半弰 3攵勱赴欤检殧雮挫毄 (6鞗� 30鞚� 膦呺): 毵れ稖鞚€ 鞝勲厔雽€牍� 15% 歃濌皜頃� 2鞏� 4,430毵� 雼煬毳� 旮半頄堨溂氅�, Universal Technical Institute (UTI) +12%, Concorde +21%鞚� 靹膘灔鞐� 頌橃瀰鞐堨姷雼堧嫟. 鞓侅梾鞚挫澋鞚€ 瓯办潣霊� 氚半 歃濌皜頃橃棳 1,420毵� 雼煬毳� 旮半頄堦碃, 毵堨鞚€ 6.9%搿� 靸侅姽頄堨姷雼堧嫟(鞚挫爠 4.2%). 靾滌澊鞚奠潃 114% 歃濌皜頃橃棳 1,070毵� 雼煬鞐� 雼枅鞙茧┌, 頋劃欤茧嫻靾滌澊鞚�(EPS)鞚€ 0.19雼煬搿� 鞚挫爠 0.09雼煬鞐愳劀靸侅姽頄堨姷雼堧嫟. 9臧滌洈旮瓣皠霃欖晥毵れ稖鞚€ 14% 歃濌皜頃� 6鞏� 1,320毵� 雼煬, 靾滌澊鞚奠潃 91% 歃濌皜頃� 4,430毵� 雼煬(頋劃欤茧嫻 0.80雼煬)毳� 旮半頄堨姷雼堧嫟.

順勱笀氚� 鞛愲掣: 順勱笀鞚€ 1鞏� 6,190毵� 雼煬鞐愳劀 7,070毵� 雼煬搿� 臧愳唽頄堨溂氅�, 5,600毵� 雼煬鞚� 須岇爠雽€於滉笀鞚� 靸來櫂霅橁碃 5,460毵� 雼煬臧€ 毵岅赴氤挫湢毂勱秾鞙茧 鞝勴櫂霅橃棃鞀惦媹雼�. 齑� 攵€毂勲姅 41% 臧愳唽頃� 7,380毵� 雼煬毳� 旮半頄堨溂氅�, 霠堧矂毽 瓿勳暯臁瓣贝鞚€ 於╈”頄堨溂雮� 0.62鞚� 雼轨牍勳湪(鞖旉惮旃� 0.65) 霑岆鞐� 鞚€頄夓潣氅挫牅臧€ 頃勳殧頄堨姷雼堧嫟. 鞓侅梾順勱笀頋愲鞚€ 4,020毵� 雼煬搿� 臧滌劆霅橃棃鞀惦媹雼�(鞚挫爠 1,840毵� 雼煬雽€牍�). 氤错喌欤� 靾橂姅鞁滊Μ歃� A 鞖办劆欤检潣鞕勳爠鞝勴櫂鞙茧 5,440毵� 欤茧 歃濌皜頄堨溂氅�, 鞐瓣皠氚半嫻旮� 100毵� 雼煬臧€ 鞝滉卑霅橃棃鞀惦媹雼�. 鞛ル秬臧€旃橂姅須岅硠鞐半弰毵� 鞚错泟 18% 歃濌皜頃� 3鞏� 680毵� 雼煬鞛呺媹雼�.

鞝勲 氚� 鞙勴棙: 靸堧鞖� 臧€鞚措崢鞀る姅氚滍憸霅橃 鞎婌晿鞀惦媹雼�. 欤检殧甏€彀� 靷暛鞚€ Title IV 攴滌牅雲胳稖, 鞚胳垬韱淀暕, 旌犿嵓鞀� 韱淀暕氚� 鞝侅爤頃� 鞙犽彊靹� 鞙犾鞛呺媹雼�.

Positive

Revenue grew 15% YoY and operating income +90%, evidencing scalable cost structure.
Long-term debt cut 41% to $73.8 m, reducing leverage and interest expense.
Operating cash flow more than doubled to $40.2 m for the nine-month period.
Conversion of Series A preferred removed future dividend drag and simplified equity.

Negative

Cash balance declined 56% since FY-end, with funds locked in less-liquid HTM bonds.
Quick-ratio covenant breach required a waiver, highlighting liquidity sensitivity.
Deferred revenue dropped 28%, hinting at potential enrollment softness.
Continued heavy dependence on Title IV funding maintains regulatory risk profile.

Insights

TL;DR: Strong top-line growth, margin expansion and deleveraging outweigh liquidity dip.

Q3 revenue accelerated to 15% YoY, reflecting continued enrollment momentum and Concorde acquisition synergies. SG&A containment held expense growth below sales, doubling operating profit. Debt repayments shaved interest expense by 35%, boosting EPS. Cash drawdown is intentional鈥攎anagement redeployed excess cash into securities while shrinking revolver usage, a net positive for balance-sheet efficiency. Preferred conversion and rising book value improve equity metrics. Management鈥檚 silence on guidance is unsurprising given the regulatory backdrop, but current run-rate supports FY EPS north of $1 if trends persist.

TL;DR: Liquidity covenant breach flag, regulatory and enrollment risks persist.

Although a waiver was secured, failing the quick-ratio signals tight short-term liquidity after large bond purchases. Deferred revenue fell 28%, possibly foreshadowing softer starts. Heavy reliance on Title IV (no mix change disclosed) leaves earnings exposed to upcoming rulemakings. Integration of 32 campuses across two brands raises execution risk, and multiple new leases elevate fixed-cost leverage. Still, interest-rate hedges and long debt maturities mitigate refinancing risk.

08/07/2025 - 08:35 AM

00012616549/302025Q3falsehttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2025#LongTermDebtCurrenthttp://fasb.org/us-gaap/2025#LongTermDebtCurrenthttp://fasb.org/us-gaap/2025#LongTermDebtNoncurrenthttp://fasb.org/us-gaap/2025#LongTermDebtNoncurrentiso4217:USDxbrli:sharesxbrli:sharesiso4217:USDuti:segmentuti:campusuti:stateuti:leasexbrli:pureuti:locationuti:voteuti:institution00012616542024-10-012025-06-3000012616542025-06-3000012616542024-09-3000012616542025-08-0100012616542025-04-012025-06-3000012616542024-04-012024-06-3000012616542023-10-012024-06-300001261654us-gaap:CommonStockMember2024-09-300001261654us-gaap:PreferredStockMember2024-09-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-09-300001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2024-09-300001261654us-gaap:TreasuryStockCommonMember2024-09-300001261654us-gaap:RetainedEarningsMember2024-09-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001261654us-gaap:RetainedEarningsMember2024-10-012024-12-3100012616542024-10-012024-12-310001261654us-gaap:CommonStockMember2024-10-012024-12-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001261654us-gaap:CommonStockMember2024-12-310001261654us-gaap:PreferredStockMember2024-12-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310001261654us-gaap:TreasuryStockCommonMember2024-12-310001261654us-gaap:RetainedEarningsMember2024-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-3100012616542024-12-310001261654us-gaap:RetainedEarningsMember2025-01-012025-03-3100012616542025-01-012025-03-310001261654us-gaap:CommonStockMember2025-01-012025-03-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001261654us-gaap:CommonStockMember2025-03-310001261654us-gaap:PreferredStockMember2025-03-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-03-310001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-03-310001261654us-gaap:TreasuryStockCommonMember2025-03-310001261654us-gaap:RetainedEarningsMember2025-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-3100012616542025-03-310001261654us-gaap:RetainedEarningsMember2025-04-012025-06-300001261654us-gaap:CommonStockMember2025-04-012025-06-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001261654us-gaap:CommonStockMember2025-06-300001261654us-gaap:PreferredStockMember2025-06-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-06-300001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-06-300001261654us-gaap:TreasuryStockCommonMember2025-06-300001261654us-gaap:RetainedEarningsMember2025-06-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001261654us-gaap:CommonStockMember2023-09-300001261654us-gaap:PreferredStockMember2023-09-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2023-09-300001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2023-09-300001261654us-gaap:TreasuryStockCommonMember2023-09-300001261654us-gaap:RetainedEarningsMember2023-09-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000012616542023-09-300001261654us-gaap:RetainedEarningsMember2023-10-012023-12-3100012616542023-10-012023-12-310001261654us-gaap:CommonStockMember2023-10-012023-12-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310001261654us-gaap:PreferredStockMember2023-10-012023-12-310001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001261654us-gaap:CommonStockMember2023-12-310001261654us-gaap:PreferredStockMember2023-12-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2023-12-310001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2023-12-310001261654us-gaap:TreasuryStockCommonMember2023-12-310001261654us-gaap:RetainedEarningsMember2023-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100012616542023-12-310001261654us-gaap:RetainedEarningsMember2024-01-012024-03-3100012616542024-01-012024-03-310001261654us-gaap:CommonStockMember2024-01-012024-03-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001261654us-gaap:CommonStockMember2024-03-310001261654us-gaap:PreferredStockMember2024-03-310001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-03-310001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2024-03-310001261654us-gaap:TreasuryStockCommonMember2024-03-310001261654us-gaap:RetainedEarningsMember2024-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100012616542024-03-310001261654us-gaap:RetainedEarningsMember2024-04-012024-06-300001261654us-gaap:CommonStockMember2024-04-012024-06-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001261654us-gaap:CommonStockMember2024-06-300001261654us-gaap:PreferredStockMember2024-06-300001261654us-gaap:CommonStockMemberus-gaap:AdditionalPaidInCapitalMember2024-06-300001261654us-gaap:PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2024-06-300001261654us-gaap:TreasuryStockCommonMember2024-06-300001261654us-gaap:RetainedEarningsMember2024-06-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000012616542024-06-300001261654uti:UTIMember2025-06-300001261654uti:ConcordeMember2025-06-300001261654uti:HeldToMaturitySecuritiesCurrentMember2025-06-300001261654us-gaap:OtherNoncurrentAssetsMember2025-06-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001261654us-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001261654uti:CorporateAndGovernmentBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001261654us-gaap:NotesReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001261654uti:RevolvingCreditFacilityAndTermLoansMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001261654us-gaap:LandMember2025-06-300001261654us-gaap:LandMember2024-09-300001261654srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-06-300001261654srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-06-300001261654us-gaap:BuildingAndBuildingImprovementsMember2025-06-300001261654us-gaap:BuildingAndBuildingImprovementsMember2024-09-300001261654srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2025-06-300001261654srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-06-300001261654us-gaap:LeaseholdImprovementsMember2025-06-300001261654us-gaap:LeaseholdImprovementsMember2024-09-300001261654srt:MinimumMemberuti:TrainingEquipmentMember2025-06-300001261654srt:MaximumMemberuti:TrainingEquipmentMember2025-06-300001261654uti:TrainingEquipmentMember2025-06-300001261654uti:TrainingEquipmentMember2024-09-300001261654srt:MinimumMemberuti:OfficeAndComputerEquipmentMember2025-06-300001261654srt:MaximumMemberuti:OfficeAndComputerEquipmentMember2025-06-300001261654uti:OfficeAndComputerEquipmentMember2025-06-300001261654uti:OfficeAndComputerEquipmentMember2024-09-300001261654srt:MinimumMemberuti:CurriculumDevelopmentMember2025-06-300001261654srt:MaximumMemberuti:CurriculumDevelopmentMember2025-06-300001261654uti:CurriculumDevelopmentMember2025-06-300001261654uti:CurriculumDevelopmentMember2024-09-300001261654srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2025-06-300001261654srt:MaximumMemberus-gaap:SoftwareDevelopmentMember2025-06-300001261654us-gaap:SoftwareDevelopmentMember2025-06-300001261654us-gaap:SoftwareDevelopmentMember2024-09-300001261654us-gaap:VehiclesMember2025-06-300001261654us-gaap:VehiclesMember2024-09-300001261654uti:RightOfUseAssetsForFinanceLeasesMember2025-06-300001261654us-gaap:ConstructionInProgressMember2025-06-300001261654us-gaap:ConstructionInProgressMember2024-09-300001261654uti:OperatingLeaseLeaseNotYetCommencedOneMember2025-06-300001261654srt:MinimumMember2025-06-300001261654srt:MaximumMember2025-06-300001261654us-gaap:RevolvingCreditFacilityMember2025-06-300001261654us-gaap:RevolvingCreditFacilityMember2024-09-300001261654uti:AvondaleTermLoanMember2025-06-300001261654uti:AvondaleTermLoanMember2024-09-300001261654uti:LisleTermLoanMember2025-06-300001261654uti:LisleTermLoanMember2024-09-300001261654uti:FinanceLeasesMember2025-06-300001261654uti:FinanceLeasesMember2024-09-300001261654us-gaap:RevolvingCreditFacilityMemberuti:VariableRateComponentOneMember2024-10-012025-06-300001261654uti:AvondaleTermLoanMember2024-10-012025-06-300001261654uti:LisleTermLoanMember2024-10-012025-06-300001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2022-11-180001261654us-gaap:LetterOfCreditMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMember2025-07-310001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2024-09-260001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2024-09-262024-09-260001261654us-gaap:RevolvingCreditFacilityMemberus-gaap:PrimeRateMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2022-11-182022-11-180001261654us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberuti:FifthThirdBankMembersrt:MinimumMemberus-gaap:LineOfCreditMember2024-09-262024-09-260001261654us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberuti:FifthThirdBankMembersrt:MaximumMemberus-gaap:LineOfCreditMember2024-09-262024-09-260001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2024-10-012025-06-300001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMember2025-06-300001261654us-gaap:RevolvingCreditFacilityMemberuti:FifthThirdBankMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMember2025-07-310001261654us-gaap:LetterOfCreditMemberuti:FifthThirdBankMemberus-gaap:SubsequentEventMember2025-07-310001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2021-05-120001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2021-05-122021-05-120001261654us-gaap:SecuredOvernightFinancingRateSofrMemberuti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2023-04-032023-04-030001261654us-gaap:SecuredOvernightFinancingRateSofrMemberuti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2023-04-030001261654uti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-140001261654uti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-142022-04-140001261654us-gaap:SecuredOvernightFinancingRateSofrMemberuti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-142022-04-140001261654uti:CreditFacilityAndTermLoansMember2025-06-300001261654uti:TermLoanFacilityMember2025-06-300001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2023-03-310001261654uti:FifthThirdBankNationalAssociationMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-140001261654uti:FifthThirdBankNationalAssociationMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-142022-04-140001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberuti:AvondaleSwapMemberus-gaap:CashFlowHedgingMember2025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberuti:LisleSwapMemberus-gaap:CashFlowHedgingMember2025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2025-04-012025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-10-012025-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-04-012024-06-300001261654us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-10-012024-06-300001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMember2023-12-050001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2024-10-012024-12-310001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2024-10-012025-06-300001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2025-06-300001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2025-04-012025-06-300001261654uti:FacilityConsolidationMemberuti:EducationalServicesAndFacilitiesMemberuti:UTIMemberuti:CampusLocationConsolidationMember2024-10-012025-06-300001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2024-04-012024-06-300001261654uti:FacilityConsolidationMemberuti:UTIMemberuti:CampusLocationConsolidationMember2023-10-012024-06-300001261654uti:FacilityConsolidationMemberuti:EducationalServicesAndFacilitiesMemberuti:UTIMemberuti:CampusLocationConsolidationMember2023-10-012024-06-300001261654uti:FacilityConsolidationMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberuti:UTIMemberuti:CampusLocationConsolidationMember2023-10-012024-06-300001261654uti:FacilityConsolidationMembersrt:MaximumMemberuti:UTIMemberuti:CampusLocationConsolidationMember2025-06-300001261654us-gaap:SeriesAPreferredStockMember2025-06-300001261654us-gaap:SeriesAPreferredStockMember2024-09-300001261654us-gaap:SeriesAPreferredStockMember2023-12-180001261654us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2023-12-182023-12-180001261654us-gaap:SeriesAPreferredStockMember2023-12-182023-12-1800012616542020-12-100001261654us-gaap:RestrictedStockMember2025-04-012025-06-300001261654us-gaap:RestrictedStockMember2024-04-012024-06-300001261654us-gaap:RestrictedStockMember2024-10-012025-06-300001261654us-gaap:RestrictedStockMember2023-10-012024-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2025-04-012025-06-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2025-04-012025-06-300001261654us-gaap:CorporateNonSegmentMember2025-04-012025-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-04-012024-06-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-04-012024-06-300001261654us-gaap:CorporateNonSegmentMember2024-04-012024-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-10-012025-06-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-10-012025-06-300001261654us-gaap:CorporateNonSegmentMember2024-10-012025-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2023-10-012024-06-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2023-10-012024-06-300001261654us-gaap:CorporateNonSegmentMember2023-10-012024-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2025-06-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2025-06-300001261654us-gaap:CorporateNonSegmentMember2025-06-300001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-09-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-09-300001261654us-gaap:CorporateNonSegmentMember2024-09-300001261654uti:AccreditingCommissionOfCareerSchoolAndCollegesMemberuti:ConcordeCareerCollegesIncMember2025-06-300001261654uti:CouncilOnOccupationalEducationMemberuti:ConcordeCareerCollegesIncMember2025-06-30

__________________________________________________________________________________________________________

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ______

Commission File Number: 1-31923

UNIVERSAL TECHNICAL INSTITUTE, INC.

(Exact name of registrant as specified in its charter)

Delaware

86-0226984

(State or other jurisdiction of
incorporation or organization)

(IRS Employer Identification No.)

4225 East Windrose Drive, Suite 200

Phoenix, Arizona 85032

(Address of principal executive offices, including zip code)

(623) 445-9500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value	UTI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer ¨			Accelerated filer þ
Non-accelerated filer ¨			Smaller reporting company ☐
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

At August 1, 2025, there were 54,423,611 shares outstanding of the registrant's common stock.

UNIVERSAL TECHNICAL INSTITUTE, INC.

INDEX TO FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2025


		Page
		Number
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS		ii

PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets at June 30, 2025 and September 30, 2024 (Unaudited)	1
	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended June 30, 2025 and 2024 (Unaudited)	2
	Condensed Consolidated Statements of Other Comprehensive Income for the Three and Nine Months Ended June 30, 2025 and 2024 (Unaudited)	3
	Condensed Consolidated Statements of Shareholders’ Equity as of June 30, 2025 and 2024 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended June 30, 2025 and 2024 (Unaudited)	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	38

PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	39
Item 1A.	Risk Factors	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 3.	Defaults upon Senior Securities	39
Item 4.	Mine Safety Disclosures	39
Item 5.	Other Information	39
Item 6.	Exhibits	40

SIGNATURES		41

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and the documents incorporated by reference herein contain forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and Section 27A of the Securities Act of 1933, as amended (“Securities Act”)), which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. From time to time, we also provide forward-looking statements in other materials we release to the public as well as verbal forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions (including the negative form of such expressions) intended to identify forward-looking statements, although not all forward looking statements contain these identifying words. Forward-looking statements are based on our current expectations and assumptions, do not strictly relate to historical or current facts, any of which may not prove to be accurate. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Important factors that could cause actual results to differ from those in our forward-looking statements include, without limitation:

•failure of our schools to comply with the extensive regulatory requirements for school operations;

•shifts in higher education laws, regulation and policy at the federal and state levels;

•our failure to maintain eligibility for or our ability to process federal student financial assistance funds;

•the effect of current and future Title IV Program regulations arising out of negotiated rulemakings, including any potential reductions in funding or restrictions on the use of funds received through Title IV Programs;

•the effect of future legislative or regulatory initiatives related to veterans’ benefit programs;

•continued Congressional examination of the for-profit education sector;

•regulatory investigations of, or actions commenced against, us or other companies in our industry;

•our failure to execute on our growth and diversification strategy, including effectively identifying, establishing and operating additional schools, programs or campuses;

•our failure to realize the expected benefits of our acquisitions, or our failure to successfully integrate our acquisitions;

•our failure to improve underutilized capacity at certain of our campuses;

•enrollment declines or challenges in our students’ ability to find employment as a result of macroeconomic conditions;

•our failure to maintain and expand existing industry relationships and develop new industry relationships;

•our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes;

•a loss of our senior management or other key employees;

•failure to comply with the restrictive covenants and our ability to pay the amounts when due under our credit agreements;

•the effect of our principal stockholder owning a significant percentage of our capital stock, and thus being able to influence certain corporate matters and the potential in the future to gain substantial control over our company;

•the effect of public health pandemics, epidemics or outbreak, including COVID-19; and

•risks related to other factors discussed in our 2024 Annual Report on Form 10-K filed with the SEC on December 5, 2024 (the “2024 Annual Report on Form 10-K”).

The factors above are not exhaustive, and new factors may emerge or changes to the foregoing factors may occur that could impact our business. We cannot guarantee that any forward-looking statement will be realized. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated,

Table of Contents

estimated or projected. Among the factors that could cause actual results to differ materially are the factors discussed under Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You should bear this in mind as you consider forward-looking statements.

Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Except as required by law, we undertake no obligation to update or revise forward looking statements, whether as a result of new information, future events or otherwise. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. We qualify all of the forward-looking statements in this Quarterly Report on Form 10-Q, including the documents that we incorporate by reference herein, by these cautionary statements. You are advised, however, to consult any further disclosures we make on related subjects in our reports and filings with the Securities and Exchange Commission (“SEC”).

iii

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and per share amounts)

(Unaudited)


	June 30, 2025		September 30, 2024
Assets
Cash and cash equivalents	$	70,672	$	161,900
Restricted cash	2,727		5,572
Held-to-maturity investments	47,162		—
Receivables, net	37,206		31,096
Notes receivable, current portion	6,504		6,200

Prepaid expenses	13,947		11,945
Other current assets	6,962		5,238
Total current assets	185,180		221,951

Property and equipment, net	267,717		264,797
Goodwill	28,459		28,459
Intangible assets, net	17,567		18,229
Notes receivable, less current portion	40,014		36,267
Right-of-use assets for operating leases	175,382		158,778
Deferred tax assets, net	2,953		3,563
Other assets	23,487		12,531
Total assets	$	740,759	$	744,575
Liabilities and Shareholders’ Equity
Accounts payable and accrued expenses	$	91,278	$	83,866
Deferred revenue	67,043		92,538
Operating lease liabilities, current portion	18,733		22,210
Long-term debt, current portion	2,822		2,697
Other current liabilities	5,149		3,652
Total current liabilities	185,025		204,963
Deferred tax liabilities, net	4,696		4,696
Operating lease liabilities	168,508		146,831
Long-term debt	70,942		123,007
Other liabilities	4,801		4,847
Total liabilities	433,972		484,344
Commitments and contingencies (Note 14)
Shareholders’ equity:
Common stock, $0.0001 par value, 100,000 shares authorized, 54,506 and 53,899 shares issued, 54,424 and 53,817 shares outstanding as of June 30, 2025 and September 30, 2024, respectively	5		5

Paid-in capital - common	223,362		220,976

Treasury stock, at cost, 82 shares as of June 30, 2025 and September 30, 2024	(365)		(365)
Retained earnings	82,771		38,509
Accumulated other comprehensive income	1,014		1,106
Total shareholders’ equity	306,787		260,231
Total liabilities and shareholders’ equity	$	740,759	$	744,575

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Revenues	$	204,298	$	177,458	$	613,174	$	536,329
Operating expenses:
Educational services and facilities	105,604		95,277		308,233		285,174
Selling, general and administrative	84,542		74,735		246,458		218,286
Total operating expenses	190,146		170,012		554,691		503,460
Income from operations	14,152		7,446		58,483		32,869
Other income (expense):
Interest income	1,445		1,440		4,833		4,842
Interest expense	(1,394)		(2,149)		(4,724)		(7,204)

Other income (expense), net	149		20		123		353
Total other income (expense), net	200		(689)		232		(2,009)
Income before income taxes	14,352		6,757		58,715		30,860
Income tax expense (Note 12)	(3,689)		(1,772)		(14,453)		(7,699)
Net income	$	10,663	$	4,985	$	44,262	$	23,161
Preferred stock dividends	—		—		—		(1,097)
Income available for distribution	$	10,663	$	4,985	$	44,262	$	22,064
Income allocated to participating securities	—		—		—		(2,855)
Net income available to common shareholders	$	10,663	$	4,985	$	44,262	$	19,209

Earnings per share (Note 16):
Net income per share - basic	$	0.20	$	0.09	$	0.82	$	0.40
Net income per share - diluted	$	0.19	$	0.09	$	0.80	$	0.39

Weighted average number of shares outstanding (Note 16):
Basic	54,412		53,805		54,260		47,956
Diluted	55,635		54,951		55,502		49,041

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME

(In thousands)

(Unaudited)


	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Net income	$	10,663	$	4,985	$	44,262	$	23,161
Other comprehensive (loss) income:
Unrealized loss on interest rate swaps, net of taxes	(251)		(6)		(92)		(539)
Comprehensive income	$	10,412	$	4,979	$	44,170	$	22,622

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands) (Unaudited)


	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance at September 30, 2024	53,899	$	5	—	$	—	$	220,976	$	—	(82)	$	(365)	$	38,509	$	1,106	$	260,231
Net income	—	—		—	—		—		—		—	—		22,153		—		22,153
Issuance of common stock under stock-based compensation plans	508	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(169)	—		—	—		(4,332)		—		—	—		—		—		(4,332)
Stock-based compensation	—	—		—	—		720		—		—	—		—		—		720
Issuance of common stock upon exercise of stock options	210	—		—	—		659		—		—	—		—		—		659


Unrealized gain on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		545		545
Balance as of December 31, 2024	54,448	$	5	—	$	—	$	218,023	$	—	(82)	$	(365)	$	60,662	$	1,651	$	279,976
Net income	—	—		—	—		—		—		—	—		11,446		—		11,446
Issuance of common stock under stock-based compensation plans	46	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(5)	—		—	—		(147)		—		—	—		—		—		(147)
Stock-based compensation	—	—		—	—		3,024		—		—	—		—		—		3,024



Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(386)		(386)
Balance as of March 31, 2025	54,489	$	5	—	$	—	$	220,900	$	—	(82)	$	(365)	$	72,108	$	1,265	$	293,913
Net income	—	—		—	—		—		—		—	—		10,663		—		10,663
Issuance of common stock under stock-based compensation plans	23	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(6)	—		—	—		(196)		—		—	—		—		—		(196)
Stock-based compensation	—	—		—	—		2,658		—		—	—		—		—		2,658



Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(251)		(251)
Balance as of June 30, 2025	54,506	$	5	—	$	—	$	223,362	$	—	(82)	$	(365)	$	82,771	$	1,014	$	306,787

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (CONTINUED)

(In thousands) (Unaudited)


	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance as of September 30, 2023	34,157	$	3	676	$	—	$	151,439	$	66,481	(82)	$	(365)	$	5,946	$	2,463	$	225,967
Net income	—	—		—	—		—		—		—	—		10,389		—		10,389
Issuance of common stock under stock-based compensation plans	538	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(178)	—		—	—		(2,054)		—		—	—		—		—		(2,054)
Stock-based compensation	—	—		—	—		1,482		—		—	—		—		—		1,482
Preferred stock dividends	—	—		—	—		—		—		—	—		(1,097)		—		(1,097)
Preferred share repurchase	—	—		(33)	—		—		(3,275)		—	—		(8,341)		—		(11,616)
Preferred stock conversion	19,297	2		(643)	—		63,204		(63,206)		—	—		—		—		—
Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(886)		(886)
Balance as of December 31, 2023	53,814	$	5	—	$	—	$	214,071	$	—	(82)	$	(365)	$	6,897	$	1,577	$	222,185
Net income	—	—		—	—		—		—		—	—		7,787		—		7,787
Issuance of common stock under stock-based compensation plans	74	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(4)	—		—	—		(65)		—		—	—		—		—		(65)

Stock-based compensation	—	—		—	—		2,353		—		—	—		—		—		2,353


Unrealized gain on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		353		353
Balance as of March 31, 2024	53,884	$	5	—	$	—	$	216,359	$	—	(82)	$	(365)	$	14,684	$	1,930	$	232,613
Net income	—	—		—	—		—		—		—	—		4,985		—		4,985
Issuance of common stock under stock-based compensation plans	15	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(5)	—		—	—		(72)		—		—	—		—		—		(72)


Stock-based compensation	—	—		—	—		1,863		—		—	—		—		—		1,863


Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(6)		(6)
Balance as of June 30, 2024	53,894	$	5	—	$	—	$	218,150	$	—	(82)	$	(365)	$	19,669	$	1,924	$	239,383

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) (Unaudited)


	Nine Months Ended June 30,
	2025		2024
Cash flows from operating activities:
Net income	$	44,262	$	23,161
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,452		21,562

Amortization of right-of-use assets for operating leases	17,492		16,468


Provision for credit losses	15,063		5,066
Stock-based compensation	6,402		5,698
Deferred income taxes	579		(2,336)


Training equipment credits earned, net	(108)		1,309
Unrealized loss on interest rate swaps, net of taxes	(92)		(539)
Other losses, net	1,179		137
Changes in assets and liabilities:
Receivables	(21,895)		(9,867)
Prepaid expenses and other current assets	(4,499)		(7,316)
Other assets	(5,383)		(2,380)
Notes receivable	(4,051)		(4,695)
Accounts payable, accrued expenses and other current liabilities	6,455		9,033
Deferred revenue	(25,495)		(19,761)
Income tax payable/receivable	3,598		(342)

Operating lease liabilities	(16,758)		(15,946)
Other liabilities	(975)		(891)
Net cash provided by operating activities	40,226		18,361
Cash flows from investing activities:

Purchase of property and equipment	(25,499)		(16,769)
Purchase of held-to-maturity investments	(54,648)		—
Proceeds received upon maturity of investments	1,874		—
Proceeds from insurance policy	—		261
Net cash used in investing activities	(78,273)		(16,508)
Cash flows from financing activities:
Proceeds from revolving credit facility	6,000		36,000
Payments on revolving credit facility	(56,000)		(59,000)

Payment of term loans and finance leases	(2,010)		(1,870)

Preferred share repurchase	—		(11,503)
Payments of preferred stock cash dividend	—		(1,097)
Proceeds from stock option exercises	659		—
Payment of payroll taxes on stock-based compensation through shares withheld	(4,675)		(2,191)

Net cash used in financing activities	(56,026)		(39,661)
Change in cash, cash equivalents and restricted cash	(94,073)		(37,808)
Cash and cash equivalents, beginning of period	161,900		151,547
Restricted cash, beginning of period	5,572		5,377
Cash, cash equivalents and restricted cash, beginning of period	167,472		156,924
Cash and cash equivalents, end of period	70,672		115,505
Restricted cash, end of period	2,727		3,611
Cash, cash equivalents and restricted cash, end of period	$	73,399	$	119,116

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(In thousands)

(Unaudited)


	Nine Months Ended June 30,
	2025		2024
Supplemental disclosure of cash flow information:
Income taxes paid (refunds received), net	$	10,364	$	9,968
Interest paid	4,946		8,052

Supplemental schedule of noncash investing and financing activities:
Training equipment obtained in exchange for services	$	930	$	702
Depreciation of training equipment obtained in exchange for services	502		412
Change in accrued capital expenditures during the period	(1,321)		(1,263)

Conversion of Series A Preferred Stock	—		63,206

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 1 - Nature of the Business

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. We have two reportable segments as follows:

Universal Technical Institute (“UTI”): UTI operates 15 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs. UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, certificate and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs as “Concorde Career College” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their healthcare careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. Additional information about our reportable segments is presented in Note 17.

Our primary source of revenues is currently tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), which are administered by the U.S. Department of Education (“ED”), as well as from various veterans’ benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 23 on “Government Regulation and Financial Aid” included in our 2024 Annual Report on Form 10-K.

Note 2 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, our condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. Normal and recurring adjustments considered necessary for a fair statement of the results for the interim periods have been included. Operating results for the nine months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the year ending September 30, 2025. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2024 Annual Report on Form 10-K. Certain prior period amounts have been reclassified to conform to the current period presentation.

The unaudited condensed consolidated financial statements include the accounts of Universal Technical Institute, Inc. and our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

There have been no material changes or developments in our significant accounting policies or evaluation of accounting estimates and underlying assumptions or methodologies from those disclosed in Note 2 of our 2024 Annual Report on Form 10-K.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 3 - Recent Accounting Pronouncements

The Financial Accounting Standards Board (“FASB”) and the SEC periodically issue new accounting standards or disclosure requirements in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued pronouncements and concluded the following new accounting standard updates (“ASU”) or SEC rules apply to us.

Effective in Fiscal 2025

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We will be adding the necessary additional disclosures to conform to this standard beginning with the filing of our Form 10-K for fiscal 2025 and Form 10-Q for the first quarter of fiscal 2026.

Effective in Fiscal 2026

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2027

In July 2025, the FASB issued ASU 2025‑05, Financial Instruments – Credit Losses (Topic 326‑20): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which introduces a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of current accounts receivable and current contract assets. Entities are required to disclose whether they elected the practical expedient and, if applicable, the cut‑off date for evaluating subsequent collections. This new guidance is effective on a prospective basis for annual periods beginning after December 15, 2025 and interim reporting periods beginning after December 15, 2026. Early adoption is permitted in both interim and annual financial statements that have not yet been issued. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2028

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses, which requires additional disclosure of certain amounts included in the expense captions presented on the statement of operations, as well as disclosures about selling expenses. As clarified in ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the effective date, this new guidance is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted for annual financial statements that have not yet been issued. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 4 - Revenue from Contracts with Customers

Nature of Goods and Services

Revenues across the UTI and Concorde segments consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues from dealer technician training and staffing services to manufacturers. All of these revenues are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both the UTI and Concorde segments. See Note 17 for disaggregated segment revenue information.

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:


	June 30, 2025		September 30, 2024
Receivables (1)	$	87,347	$	72,080
Deferred revenue	67,043		92,538

(1) Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

During the nine months ended June 30, 2025, the deferred revenue balance included decreases for revenues recognized during the period and increases related to new students who started their training programs during the period.

Note 5 - Investments

In February 2025, we invested a portion of our cash and cash equivalents in short-term investments which primarily consist of corporate and government bonds with a minimum credit rating of A. We have the ability and intention to hold these investments until maturity and therefore classified these investments as held-to-maturity. We recorded these at amortized cost and presented the bonds maturing in less then one year in “Held-to-maturity investments” and the bonds maturing in greater than one year in “Other assets” on our condensed consolidated balance sheet as of June 30, 2025. For the year ended September 30, 2024, there were no held-to-maturity investments.

The amortized cost, gross unrealized gains or losses, and fair value of investments classified as held-to-maturity at June 30, 2025 were as follows:


	June 30, 2025
			Gross Unrealized				Estimated Fair
Corporate and government bonds	Amortized Cost		Gains		Losses		Market Value
Due in less than 1 year:	$	47,162	$	2	$	(20)	$	47,144
Due in more than 1 year:	5,566		3		—		5,569

Investments are exposed to various risks, including interest rate, market and credit risk. As a result, it is possible that changes in the values of these investments may occur and that such changes could affect the amounts reported in the condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 6 - Fair Value Measurements

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

Level 1: Defined as quoted market prices in active markets for identical assets or liabilities.

Level 2: Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period. Assets measured or disclosed at fair value on a recurring basis consisted of the following:


			Fair Value Measurements Using
	June 30, 2025		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	51,964	$	51,964	$	—	$	—
Corporate and government bonds(2)	52,713		52,713		—		—
Notes receivable(3)	46,518		—		—		46,518
Total assets at fair value on a recurring basis	$	151,195	$	104,677	$	—	$	46,518

Revolving credit facility and term loans(4)	70,001		—		70,001		—
Total liabilities at fair value on a recurring basis	$	70,001	$	—	$	70,001	$	—


			Fair Value Measurements Using
	September 30, 2024		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	94,772	$	94,772	$	—	$	—
Corporate and government bonds(2)	—		—		—		—
Notes receivable(3)	42,467		—		—		42,467
Total assets at fair value on a recurring basis	$	137,239	$	94,772	$	—	$	42,467

Revolving credit facility and term loans(4)	121,319		—		121,319		—
Total liabilities at fair value on a recurring basis	$	121,319	$	—	$	121,319	$	—

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as “Cash and cash equivalents” in our condensed consolidated balance sheets as of June 30, 2025 and September 30, 2024.

(2) See Note 5 for further discussion on the corporate and government bonds.

(3) Notes receivable relate to UTI’s proprietary loan program and are reflected as “Notes receivable, current portion” and “Notes receivable, less current portion” in our condensed consolidated balance sheets as of June 30, 2025 and September 30, 2024.

(4) The Credit Facility and Term Loans bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 7 - Property and Equipment, net

Property and equipment, net consisted of the following:


	Depreciable Lives (in years)	June 30, 2025		September 30, 2024
Land	—	$	25,601	$	25,601
Buildings and building improvements	3-30	167,097		165,667
Leasehold improvements	1-20	98,180		94,473
Training equipment	3-10	98,349		119,171
Office and computer equipment	3-10	36,499		36,454
Curriculum development	3-5	5,475		5,127
Software developed for internal use	1-5	13,045		13,045
Vehicles	5	1,076		1,546
Right-of-use assets for finance leases	15	5,680		5,603
Construction in progress	—	16,234		6,314
Property and equipment, gross		467,236		473,001
Less: Accumulated depreciation and amortization		(199,519)		(208,204)
Property and equipment, net		$	267,717	$	264,797

Depreciation expense related to property and equipment was $8.1 million and $23.8 million for the three and nine months ended June 30, 2025, and $7.2 million and $21.1 million for the three and nine months ended June 30, 2024.

Note 8 - Leases

As of June 30, 2025, we have facility leases at 29 of our 32 operating campuses, and two non-campus locations under non-cancelable operating or finance leases. During the nine months ended June 30, 2025, we recorded the facility leases for the new Concorde co-branded Heartland Dental campus in Fort Myers, Florida which is slated to open in early fiscal 2026, the new UTI Atlanta, Georgia campus which is slated to launch in the late fiscal 2026, and the relocation of the Concorde Denver, Colorado campus planned for fiscal 2026, as we took possession to begin construction. Additionally, as part of our growth and diversity strategy, we have signed a lease agreement for a new UTI San Antonio, Texas campus which is expected to open during fiscal 2026. As of June 30, 2025, this lease which has not yet commenced nor have we taken possession of it, will have total minimum lease payments of approximately $8.2 million over a term of 10.5 years.

Some of our leases contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease certain portions of unused building space to third parties, which as of June 30, 2025, resulted in minimal income. All leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

The components of lease expense during the three and nine months ended June 30, 2025 and 2024 were as follows:


	Three Months Ended June 30,				Nine Months Ended June 30,
Lease Expense	2025		2024		2025		2024
Operating lease expense(1)	$	8,428	$	7,603	$	23,693	$	22,862
Finance lease expense:
Amortization of leased assets	227		227		681		681
Interest on lease liabilities	62		77		197		238
Variable lease expense	2,708		2,776		7,861		7,613
Sublease income	(30)		(122)		(89)		(187)
Total net lease expense	$	11,395	$	10,561	$	32,343	$	31,207

(1) Excludes the expense for short-term leases, which was not significant for the three and nine months ended June 30, 2025 and 2024.

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):


Leases	Classification	June 30, 2025		September 30, 2024
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	175,382	$	158,778
Finance lease assets	Property and equipment, net(1)	3,255		3,937
Total leased assets		$	178,637	$	162,715

Liabilities:
Current
Operating lease liabilities	Operating lease liabilities, current portion	$	18,733	$	22,210
Finance lease liabilities	Long-term debt, current portion(1)	1,004		934
Non-current
Operating lease liabilities	Operating lease liabilities	168,508		146,831
Finance lease liabilities	Long-term debt	3,073		3,834
Total lease liabilities		$	191,318	$	173,809

(1) The finance lease assets and liabilities as of June 30, 2025 and September 30, 2024 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $2.4 million and $1.7 million as of June 30, 2025 and September 30, 2024, respectively.


Lease Term and Discount Rate	June 30, 2025		September 30, 2024
Weighted-average remaining lease term (in years):
Operating leases	7.39		7.14
Finance lease	3.58		4.33

Weighted average discount rate:
Operating leases	5.05	%	4.87	%
Finance lease	6.02	%	6.02	%

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	Nine Months Ended June 30,
Supplemental Disclosure of Cash Flow and Other Information	2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	16,758	$	15,946
Financing cash flows from finance leases	692		625

Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities(1)	$	34,097	$	3,981

(1) During the nine months ended June 30, 2025, we recorded facility leases for the new Concorde co-branded Heartland campus in Fort Myers, Florida, the new UTI Atlanta, Georgia campus, and the relocation of the Concorde Denver, Colorado campus as we took possession to begin construction.

Maturities of lease liabilities were as follows:


	As of June 30, 2025
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2025	$	7,005	$	301
2026	27,263		1,226
2027	33,458		1,263
2028	31,705		1,301
2029	31,078		439
2030 and thereafter	97,854		—
Total lease payments	228,363		4,530
Less: interest	(41,122)		(453)
Present value of lease liabilities	187,241		4,077
Less: current lease liabilities	(18,733)		(1,004)
Long-term lease liabilities	$	168,508	$	3,073

Note 9 - Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:


	June 30, 2025		September 30, 2024
Accounts payable	$	22,840	$	26,273
Accrued compensation and benefits	45,398		35,660
Accrued tool sets	4,958		4,807
Other accrued expenses	18,082		17,126
Total accounts payable and accrued expenses	$	91,278	$	83,866

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 10 - Debt


	June 30, 2025					September 30, 2024
	Interest Rate		Maturity Date	Carrying Value of Debt(6)		Carrying Value of Debt(6)
Revolving Credit Facility(1)	6.14	%	Nov 2027	$	6,000	$	56,000
Avondale Term Loan(2)	6.37	%	May 2028	27,726		28,390
Lisle Term Loan(3)	6.32	%	Apr 2029	36,275		36,929
Finance lease(4)	6.02	%	Jan 2029	4,077		4,768
Total debt				74,078		126,087
Debt issuance costs presented with debt (5)				(314)		(383)
Total debt, net				73,764		125,704
Less: current portion of long-term debt				(2,822)		(2,697)
Long-term debt				$	70,942	$	123,007

(1) Interest on the Revolving Credit Facility (as defined below) accrues at an annual rate equal to Daily Term SOFR plus a margin of 1.85%.

(2) Interest on the Avondale Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0% and a tranche adjustment of 0.046%.

(3) Interest on the Lisle Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0%.

(4) The finance lease is related to a facility lease with an annual interest rate of 6.02% that matures in 2029. See Note 8 for additional details on our finance lease.

(5) The unamortized debt issuance costs relate to the Avondale Term Loan and the Lisle Term Loan.

(6) The Revolving Credit Facility, Avondale Term Loan, Lisle Term Loan and finance leases bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Revolving Credit Facility

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility with Fifth Third Bank (the “Credit Facility” or “Revolving Credit Facility”), which included a $20.0 million sub facility available for letters of credit. On September 26, 2024, we amended the Credit Facility to increase the commitment amount to $125.0 million, extend the maturity date to November 30, 2027, and provide for the option to request an increase of up to an additional $25.0 million, which may be granted at the lender’s discretion to grant such increase. Advances made under the Credit Facility bear interest at an annual rate equal to (i) the Term SOFR rate, (ii) the Daily Simple SOFR rate, or (iii) the Base Rate (i.e., the greater of 3.5% and the lender’s prime rate). In each case that a SOFR rate is selected, an applicable margin that varies from 1.85% up to 2.35%, based on our then-current total leverage ratio, is applied.

During the nine months ended June 30, 2025, we made payments on the Credit Facility of $56.0 million and we received proceeds of $6.0 million. The remaining availability under the Credit Facility as of June 30, 2025 was $119.0 million.

In July 2025, we used cash on hand to repay $6.0 million outstanding on the Credit Facility. Additionally in July 2025, we issued a letter of credit for $19.6 million, with an expiration date of June 30, 2026, to the ED in order to lift the core growth restrictions imposed on Concorde and MIAT campuses as a result of our acquisitions. These two transactions reduced the overall availability under the Credit Facility to $105.4 million and sub facility available for letters of credit to $0.4 million, respectively. It is likely that we will borrow from the Credit Facility in future periods based on future working capital or other needs.

Avondale Term Loan

In connection with the Avondale, Arizona building purchase in December 2020, we entered into a credit agreement with Fifth Third Bank (the “Avondale Lender”) on May 12, 2021 in the maximum principal amount of $31.2 million with a maturity of

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

seven years (the “Avondale Term Loan”). The Avondale Term Loan bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046%. Principal and interest payments are due monthly. The Avondale Term Loan is secured by a first priority lien on our Avondale, Arizona property, including all land and improvements. Additionally, we entered into an interest rate swap agreement with the Avondale Lender. See Note 11 for further discussion on the interest rate swap.

Lisle Term Loan

On April 14, 2022, our consolidated subsidiary, 2611 Corporate West Drive Venture LLC (the “Borrower”), entered into a new Loan Agreement (“Lisle Loan Agreement”) with Valley National Bank (the “Lisle Lender”), to fund the acquisition and retire the prior loan agreement with Western Alliance bank, via a term loan in the original principal amount of $38.0 million with a maturity of seven years (the “Lisle Term Loan” and together with the Avondale Term Loan, the “Term Loans”). The Lisle Term Loan bears interest at a rate of one-month Term SOFR plus 2.0%. The Lisle Term Loan is secured by a mortgage on the Lisle, Illinois campus and is guaranteed by the Company. In connection with the Lisle Term Loan, we entered into an interest rate swap agreement. See Note 11 for further discussion on the interest rate swap.

Debt Covenants for our Credit Facility and Term Loans

We are subject to certain customary affirmative and negative covenants under the Revolving Credit Facility and the Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on liens, encumbrances and indebtedness and various financial covenants, including debt service coverage ratios. As of June 30, 2025, we were in compliance with our debt covenants under our Term Loans. Under our Revolving Credit Facility, however, while we were in compliance with the Fixed Charge Coverage and Leverage ratios, our Quick Ratio of 0.62 at June 30, 2025 did not meet the required Quick Ratio of 0.65. The failure of this covenant was primarily due to paying down the Revolving Credit Facility with available cash and additional cash investments in held-to-maturity securities which are excluded from the Quick Ratio calculation. We have obtained a waiver for the failure to meet the Quick Ratio covenant as of June 30, 2025 from Fifth Third Bank.

Debt Maturities

Scheduled principal payments due on our debt for the remainder of 2025 and for each fiscal year through the period ended September 30, 2029, and thereafter were as follows at June 30, 2025:


Maturity	Revolving Credit Facility & Term Loans		Finance Lease		Total
Remainder of 2025	$	445	$	243	$	688
2026	1,837		1,029		2,866
2027	1,909		1,131		3,040
2028	32,610		1,239		33,849
2029	33,200		435		33,635
Thereafter	—		—		—
Subtotal	70,001		4,077		74,078
Debt issuance costs presented with debt	(314)		—		(314)
Total	$	69,687	$	4,077	$	73,764

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 11 - Derivative Financial Instruments

In the normal course of business, our operations are exposed to market risks, including the effect of changes in interest rates. We may enter into derivative financial instruments to offset these underlying market risks.

On March 31, 2023, we entered into a new interest rate swap agreement, effective April 3, 2023, with the Avondale Lender that effectively fixes the interest rate we pay on 50% of the principal amount of the Avondale Term Loan at 1.45% for the entire loan term (the “Avondale Swap”). The Avondale Swap was designated as an effective cash flow hedge for accounting and tax purposes. On April 14, 2022, in connection with the Lisle Term Loan, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan at 4.69% for the entire loan term, or seven years (the “Lisle Swap”). The Lisle Swap was designated as an effective cash flow hedge for accounting and tax purposes.

Changes in the fair value of derivatives that are designated and qualify as cash flow hedges are recorded in “Accumulated other comprehensive income” on the condensed consolidated balance sheets. For cash flow hedges, we report the effective portion of the gain or loss as a component of “Accumulated other comprehensive income” and reclassify it to “Interest expense” in the condensed consolidated statements of operations over the corresponding period of the underlying hedged item. The ineffective portion of the change in fair value of a derivative financial instrument is recognized in “Interest expense” at the time the ineffectiveness occurs. To the extent the hedged forecasted interest payments on debt related to our interest rate swap is paid off, the remaining balance in “Accumulated other comprehensive income” is recognized in “Interest expense” in the condensed consolidated statements of operations. Of the net amount of the existing gains that are reported in “Accumulated other comprehensive income” as of June 30, 2025, we estimate that $0.5 million will be reclassified to “Interest expense” within the next twelve months. As of June 30, 2025, the notional amount of the Avondale Swap and Lisle Swap was approximately $13.9 million and $18.1 million, respectively.

Fair Value of Derivative Instruments

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheets as of June 30, 2025 and September 30, 2024:


Interest Rate Swaps	June 30, 2025		September 30, 2024
Other current assets	$	486	$	497
Other assets	615		726
Total fair value of assets designated as hedging instruments	$	1,101	$	1,223

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Operations and Accumulated Other Comprehensive Income

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and “Accumulated other comprehensive income” for the three and nine months ended June 30, 2025 and 2024:


	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes	Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended June 30, 2025
Avondale Swap and Lisle Swap	$(74)	$176

	Nine Months Ended June 30, 2025
Avondale Swap and Lisle Swap	$471	$563

	Three Months Ended June 30, 2024
Avondale Swap and Lisle Swap	$259	$264

	Nine Months Ended June 30, 2024
Avondale Swap and Lisle Swap	$263	$802

Note 12 - Income Taxes

Our income tax expense for the three months ended June 30, 2025 was $3.7 million, or 25.7% of pre-tax income, compared to $1.8 million, or 26.2% of pre-tax income, for the three months ended June 30, 2024. For the nine months ended June 30, 2025, our income tax expense was $14.5 million, or 24.6% of pre-tax income, compared to $7.7 million, or 24.9% of pre-tax income, for the nine months ended June 30, 2024. The effective income tax rate for the three and nine months ended June 30, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three and nine months ended June 30, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes.

As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of June 30, 2025, we continued to maintain a valuation allowance related to certain federal and state attributes, which are not expected to be utilized prior to expiration.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. We are currently assessing the impact of the new tax legislation and plan to address the impact in our annual results reported on Form 10-K for the year ended September 30, 2025.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 13 - Restructuring Costs

On December 5, 2023, UTI announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. Both facilities will remain in use post-consolidation. As part of the transition, the MIAT Houston campus, acquired in November 2021, began a phased teach-out in May 2024 and began operating under the UTI brand. The consolidation into a single UTI Houston campus was completed during the three months ended December 31, 2024, reducing the number of UTI campuses from 16 to 15.

The total costs of the restructuring plan are estimated to be approximately $1.2 million and relate to the UTI segment. From announcement through June 30, 2025, we have incurred total restructuring costs of $0.2 million.

There were no restructuring costs expensed during the three months ended June 30, 2025. During the nine months ended June 30, 2025, we expensed $43 thousand of restructuring costs primarily related to student financing costs, employee termination costs and tools, with $12 thousand reported in “Educational services and facilities” and the remainder reported in “Selling, general and administrative” on the condensed consolidated statements of operations.

During the three months ended June 30, 2024, $53 thousand of expenses, primarily related to tools, were incurred. During the nine months ended June 30, 2025, $141 thousand of expenses, primarily related to employee termination costs and tools, were incurred. Of the $141 thousand recorded during the nine months ended June 30, 2024, approximately $87 thousand was reported in “Educational services and facilities” while approximately $57 thousand was reported in “Selling, general and administrative” on the condensed consolidated statements of operations.

As of June 30, 2025, the only remaining cost related to this restructuring is the potential for federal loan discharges which we are estimating could be up to $1.0 million.

Note 14 - Commitments and Contingencies

Legal

Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claims. We are not currently a party to any material legal proceedings, but note that legal proceedings could, generally, have a material adverse effect on our business, cash flows, results of operations or financial condition.

Note 15 - Shareholders' Equity

Common Stock

Holders of our common stock are entitled to receive dividends when and as declared by our Board of Directors and have the right to one vote per share on all matters requiring shareholder approval. On June 9, 2016, our Board of Directors voted to eliminate the quarterly cash dividend on our common stock.

Preferred Stock

As of June 30, 2025 and September 30, 2024, no shares of the Series A Convertible Preferred Stock with a $0.0001 par value each (“Series A Preferred Stock”) remain outstanding.

On December 18, 2023, we entered into a preferred stock repurchase agreement, pursuant to which we repurchased 33,300 shares of Series A Preferred Stock for an aggregate purchase price of $11.3 million. Following the repurchase of those shares,

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

all remaining outstanding shares of Series A Preferred Stock were converted into Common Stock and we made a final dividend payment of $1.1 million to the Series A Preferred Stock holders of record as of December 18, 2023. As a result of the conversion, the aggregate 642,585 remaining shares of Series A Preferred Stock outstanding were converted into 19,296,843 shares of Common Stock. No shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. For further discussion, see Note 18 on “Shareholders’ Equity” included in our 2024 Annual Report on Form 10-K.

Share Repurchase Program

On December 10, 2020, our Board of Directors authorized a share repurchase plan that would allow for the repurchase of up to $35.0 million of our common stock in the open market or through privately negotiated transactions. This share repurchase plan replaced the previously authorized plan from fiscal 2012. We have not repurchased any shares under the $35.0 million share repurchase program, including during the nine months ended June 30, 2025 or 2024.

Note 16 - Earnings per Share

Prior to the preferred stock conversion, we calculated basic and diluted earnings per common share (“EPS”) pursuant to the two-class method. The two-class method is an earnings allocation formula that determines EPS for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends. Dilutive potential common shares include outstanding stock options, unvested restricted share units and convertible preferred stock. As noted above in Note 15, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date.

The following table summarizes the computation of basic and diluted EPS and the anti-dilutive shares excluded:


	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Basic earnings per common share:
Net income	$	10,663	$	4,985	$	44,262	$	23,161
Less: Preferred stock dividend declared	—		—		—		(1,097)
Net income available for distribution	10,663		4,985		44,262		22,064
Income allocated to participating securities	—		—		—		(2,855)
Net income available to common shareholders	$	10,663	$	4,985	$	44,262	$	19,209

Weighted average basic shares outstanding	54,412		53,805		54,260		47,956

Basic income per share	$	0.20	$	0.09	$	0.82	$	0.40

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Diluted earnings per common share:
Net income available to common shareholders	$	10,663	$	4,985	$	44,262	$	19,209

Weighted average basic shares outstanding	54,412		53,805		54,260		47,956
Dilutive effect related to employee stock plans	1,223		1,146		1,242		1,085
Weighted average diluted shares outstanding	55,635		54,951		55,502		49,041

Diluted income per common share	$	0.19	$	0.09	$	0.80	$	0.39

Anti-dilutive shares excluded:
Outstanding stock-based grants	3		3		1		2

Total anti-dilutive shares excluded	3		3		1		2

Note 17 - Segment Information

We operate our business in two reportable segments: (i) the UTI segment; and (ii) the Concorde segment. These segments are organized by key market segments to enhance operational alignment within each segment to more effectively execute our strategic plan. Each reportable segment represents a group of post-secondary education providers that offer a variety of degree and non-degree academic programs. “Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments and is included to reconcile segment results to the condensed consolidated financial statements.

Summary information by reportable segment is as follows:


	UTI		Concorde		Corporate		Consolidated
Three Months Ended June 30, 2025
Revenues	$	131,463	$	72,835	$	—	$	204,298
Income (loss) from operations	19,870		5,929		(11,647)		14,152
Depreciation and amortization	6,068		1,939		308		8,315
Net income (loss)	18,583		5,890		(13,810)		10,663

Three Months Ended June 30, 2024
Revenues	$	117,134	$	60,324	$	—	$	177,458
Income (loss) from operations	14,136		3,716		(10,406)		7,446
Depreciation and amortization	5,743		1,367		266		7,376
Net income (loss)	12,673		3,778		(11,466)		4,985

Nine Months Ended June 30, 2025
Revenues	$	397,169	$	216,005	$	—	$	613,174
Income (loss) from operations	66,762		26,006		(34,285)		58,483
Depreciation and amortization	18,010		5,499		943		24,452
Net income (loss)	63,090		25,892		(44,720)		44,262

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	UTI		Concorde		Corporate		Consolidated
Nine Months Ended June 30, 2024
Revenues	$	355,831	$	180,498	$	—	$	536,329
Income (loss) from operations	47,309		14,091		(28,531)		32,869
Depreciation and amortization	16,921		3,738		903		21,562
Net income (loss)	42,886		14,271		(33,996)		23,161

As of June 30, 2025
Total assets	$	463,179	$	134,184	$	143,396	$	740,759

As of September 30, 2024
Total assets	$	440,764	$	125,212	$	178,599	$	744,575

Note 18 - Government Regulation and Financial Aid

As discussed at length in our 2024 Annual Report on Form 10-K, our institutions participate in a range of government-sponsored student assistance programs. The most significant of these is the federal student aid programs administered by the ED pursuant to Title IV of the HEA, commonly referred to as the Title IV Programs. Generally, to participate in the Title IV Programs, an institution must be licensed or otherwise legally authorized to operate in the state where it is physically located, be accredited by an accreditor recognized by ED, be certified as an eligible institution by ED, offer at least one eligible program of education, and comply with other statutory and regulatory requirements.

Each of our institutions holds the state or other authorizations required to operate and offer postsecondary education programs, and to recruit in the states in which it engages in recruiting activities. In addition, our institutions are accredited by ED-recognized accreditors: all of the UTI institutions and 14 of the Concorde institutions are accredited by the Accrediting Commission of Career Schools and Colleges, while the remaining three Concorde institutions are accredited by the Council on Occupational Education. ED will certify an institution to participate in the Title IV programs only after the institution has demonstrated compliance with the HEA and ED’s extensive regulations regarding institutional eligibility. An institution must also demonstrate its compliance to ED on an ongoing basis. As of June 30, 2025, management believes the Company and its institutions are in compliance with the applicable regulations in all material respects. See “Part I, Item 1. Regulatory Environment” and “Part I, Item 1. State and Accreditor Approvals” in our 2024 Annual Report on Form 10-K for a detailed discussion of the regulatory environment in which the Company operates.

Congress periodically revises the HEA and other laws, and enacts new laws, governing Title IV Programs and determining the funding level for each Title IV Program. Congress most recently reauthorized the HEA in 2008 and, despite repeated attempts, has not completed a full reauthorization since then. In addition to HEA reauthorization, policies directly related to Title IV Programs and funding for those programs may be impacted by the annual budget and appropriations process as well as by other legislation. In this regard, on July 4, 2025, Congress enacted the OBBBA. Under the OBBBA, Congress approved amendments to the HEA that, among other things, revised certain Title IV Programs, including provisions that condition the eligibility of educational programs upon compliance with earnings benchmarks that compare former students’ median earnings after completing a program to the median earnings of working adults with lesser credential, and other provisions that will limit or reduce the amount of Title IV Program funding that may be available to some higher education students. The impact of these changes and other changes to the HEA enacted as part of the OBBBA, and of related future regulatory and policy changes, is unknown at this time.

Because the Company operates in a highly regulated industry, it, like other industry participants, may be subject from time to time to investigations, claims of non-compliance, or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions, or common law causes of action. There can be no assurance that regulatory agencies or third parties will not undertake investigations or make claims against the Company, or that such claims, if made, will not have a material adverse effect on the Company’s business, results of operations or financial condition.

Table of Contents

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our 2024 Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Risk Factors” in our 2024 Annual Report on Form 10-K and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also “Cautionary Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.

Company Overview

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, certificate and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs as “Concorde Career College” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on our segments.

All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended, commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education (“ED”). Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs and under the Workforce Innovation and Opportunity Act.

We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.

Table of Contents

Overview of the Three and Nine Months Ended June 30, 2025

Student Metrics


	Three Months Ended				Nine Months Ended
	June 30,		%		June 30,		%
	2025	2024	Change		2025	2024	Change
UTI
Total new student starts	2,829	2,916	(3.0)	%	9,173	8,070	13.7	%
Average full-time active students	14,205	13,041	8.9	%	14,815	13,724	7.9	%
End of period full-time active students	13,874	12,686	9.4	%	13,874	12,686	9.4	%
Concorde
Total new student starts	2,892	2,651	9.1	%	8,511	7,323	16.2	%
Average full-time active students	9,552	8,038	18.8	%	9,659	8,263	16.9	%
End of period full-time active students	8,495	7,442	14.1	%	8,495	7,442	14.1	%
Consolidated
Total new student starts	5,721	5,567	2.8	%	17,684	15,393	14.9	%
Average full-time active students	23,757	21,079	12.7	%	24,474	21,987	11.3	%
End of period full-time active students	22,369	20,128	11.1	%	22,369	20,128	11.1	%

For the three and nine months ended June 30, 2025, the increase in consolidated new student starts, average full-time active students and end of period full-time active students was primarily due to new program rollouts and increased student demand for existing programs across both segments as compared to the prior year. The UTI segment benefited from the successful launch of three new programs launched in the second half of fiscal 2024 and nine new programs in fiscal 2025. In the Concorde segment, increases to our student population during the three and nine months ended June 30, 2025 were primarily driven by the successful launch of five new programs at three campuses during fiscal 2024, and the introduction of new cash pay “short programs” at a number of campuses.

Our ability to start new students can be influenced by various factors including: the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education; unemployment rates; competition; adverse media coverage, legislative, or regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate “for-profit” education industry in a negative light; and pandemics and or other national, state or local emergencies as declared by various government authorities.

Operations

Revenues for the three months ended June 30, 2025 were $204.3 million, an increase of $26.8 million, or 15.1%, from the comparable period in the prior year. UTI revenues increased by approximately $14.3 million, or 12.2%, and Concorde revenues increased by approximately $12.5 million, or 20.7%. Both segment increases were primarily driven by the higher average full-time active students.

Revenues for the nine months ended June 30, 2025 were $613.2 million, an increase of $76.8 million, or 14.3%, from the comparable period in the prior year. UTI revenues increased by approximately $41.3 million, or 11.6%, and Concorde revenues increased by approximately $35.5 million, or 19.7%. Both segment increases were primarily driven by the higher average full-time active students.

Total income from operations was $14.2 million and $58.5 million during the three and nine months ended June 30, 2025, compared to $7.4 million and $32.9 million for the three and nine months ended June 30, 2024. The increase for the three and nine months ended June 30, 2025 was primarily driven by the increased revenues from the larger student population. Additionally, productivity improvements and proactive cost reductions have been a key part of our operating model for the past several years, and we continue to identify and execute on optimization opportunities throughout our operations in both segments.

Table of Contents

Business Strategy

Our business strategy, internally known as our “North Star strategy,” has three core tenets: (i) to grow the business by more deeply penetrating existing target markets and adding new markets; (ii) to diversify the business by adding new locations, programs, and offerings that maximize the lifetime value of our students; and (iii) to continually optimize the business by constantly enhancing operational efficiency.

During the nine months ended June 30, 2025, we executed the following as part of our business strategy:

•UTI announced Atlanta, Georgia as the location of the division’s next new campus (“UTI Atlanta”), continuing the company's execution of its North Star strategy. Pending regulatory approvals, UTI Atlanta will open in 2026.

•UTI announced the division’s second new campus will be in San Antonio, Texas (“UTI San Antonio”). This new campus, once open, will be the first skilled trades and energy education focused campus. Similar to above, pending regulatory approvals, UTI San Antonio will open in 2026, bringing the total number of UTI campuses nationwide to 17.

•Concorde signed a new facility lease agreement related to our partnership with Heartland Dental to construct a new co-branded campus in Fort Myers, Florida, which is expected to open in early fiscal 2026, pending regulatory approvals, and will bring the total number of Concorde campuses nationwide to 18. Construction began during the second quarter of 2025.

•UTI has announced the expansion of its successful Manufacturer Specific Advanced Training program by adding Tesla's START Collision Repair program. Tesla's START program is an intensive training program that prepares workers for successful careers at Tesla and began at the Long Beach, California campus in the third quarter of 2025.

•UTI launched its HVACR program at the Sacramento, California and Orlando, Florida campuses in March 2025. The program covers topics such as air handling, AC and DC circuits, sheet metal ductwork, and troubleshooting. This program is now offered at UTI campuses in seven states.

•UTI announced the expansion of its core automotive program to include new Battery Hybrid Electric Vehicle and Electric Vehicle (“EV”) courses with roll out completed during the first quarter of 2025 at the Avondale, Arizona and Orlando, Florida campuses. Rollouts were completed during the second quarter of 2025 at the following campuses: Bloomfield, New Jersey; Dallas, Texas; Austin, Texas; and Houston, Texas. In addition, during the third quarter of 2025, the program launched at the Miramar, Florida campus. This expansion builds on existing EV training at UTI's California campuses and covers topics such as high-voltage vehicle operation, electric vehicle components, diagnosis, and service.

•UTI announced a new partnership with FirstCall Mechanical, a leading provider of HVACR services to commercial and industrial sectors, as part of its early employment program. As part of this partnership, students in the HVACR program at Mooresville, North Carolina, Orlando, Florida, and Austin, Texas can apply for roles at FirstCall Mechanical and start working while still in school.

•UTI partnered with Loftin Equipment Company through its early employment program. Across three campuses in Texas and one campus in Arizona, this program offers diesel technology students the opportunity to gain paid work experience while completing their education. Students enrolled in the industrial maintenance program in one campus in Texas are also eligible for this opportunity.

In addition, we continue to pursue other opportunities that align with our business strategy.

Regulatory Environment

See Note 18 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.

Table of Contents

Results of Operations: Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.


	Three Months Ended June 30,
	2025		2024
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	51.7	%	53.7	%
Selling, general and administrative	41.4	%	42.1	%
Total operating expenses	93.1	%	95.8	%
Income from operations	6.9	%	4.2	%
Interest income	0.7	%	0.8	%
Interest expense	(0.7)	%	(1.2)	%
Other income (expense), net	0.1	%	—	%
Total other income (expense), net	0.1	%	(0.4)	%
Income before income taxes	7.0	%	3.8	%
Income tax expense	(1.8)	%	(1.0)	%
Net income	5.2	%	2.8	%

Revenues

The following table presents revenue by segment (in thousands):


	Three Months Ended June 30, 2025									Three Months Ended June 30, 2024
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	131,463		$	72,835		$	204,298		$	117,134	$	60,324	$	177,458
Year over Year % Change	12.2		%	20.7		%	15.1		%

Revenues for the three months ended June 30, 2025 were $204.3 million, an increase of $26.8 million, or 15.1%, as compared to revenues of $177.5 million for the three months ended June 30, 2024.

UTI

Revenues for UTI for the three months ended June 30, 2025 were $131.5 million compared to $117.1 million in the prior period. Revenue increased primarily due to an 8.9% increase in average full-time active students from the prior period.

Concorde

Revenues for Concorde for the three months ended June 30, 2025 were $72.8 million compared to $60.3 million in the prior period. Revenues increased primarily due to an 18.8% increase in average full-time active students from the prior period.

Educational services and facilities expenses

Educational services and facilities expenses were $105.6 million for the three months ended June 30, 2025, as compared to $95.3 million for the three months ended June 30, 2024. This increase was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.

The following tables set forth the significant components of our educational services and facilities expenses by segment (in thousands):

Table of Contents


	Three Months Ended June 30, 2025
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	32,881	$	27,631	$	60,512
Bonus expense	934		755		1,689
Stock-based compensation	137		—		137
Compensation and related costs	33,952		28,386		62,338
Occupancy costs	8,413		5,986		14,399
Supplies, maintenance and student expense	6,150		4,583		10,733
Depreciation and amortization expense	6,035		1,679		7,714
Contract services expense	994		583		1,577
Other educational services and facilities expense	5,545		3,298		8,843
Total educational services and facilities expense	$	61,089	$	44,515	$	105,604


	Three Months Ended June 30, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	30,139	$	23,360	$	53,499
Bonus expense	867		293		1,160
Stock-based compensation	109		—		109
Compensation and related costs	31,115		23,653		54,768
Occupancy costs	7,558		5,544		13,102
Supplies, maintenance and student expense	7,206		4,075		11,281
Depreciation and amortization expense	5,651		1,167		6,818
Contract services expense	698		501		1,199
Other educational services and facilities expense	5,297		2,812		8,109
Total educational services and facilities expense	$	57,525	$	37,752	$	95,277

UTI

Compensation and related costs increased by $2.8 million for the three months ended June 30, 2025, primarily due to instructors and other campus related personnel hired to support the new programs and overall growth in the student population.

Occupancy costs increased by $0.9 million for the three months ended June 30, 2025, primarily due to new lease activity associated with the announced new campus growth and annual rate increases on existing leases.

Supplies, maintenance and student expense decreased by $1.1 million for the three months ended June 30, 2025, primarily due to a decrease of $0.7 million in student housing expenses.

Concorde

Compensation and related costs increased by $4.7 million for the three months ended June 30, 2025, primarily due to instructors and other campus related personnel hired to support overall student growth and the launch of additional programs.

Depreciation and amortization expense increased by $0.5 million during the three months ended June 30, 2025, primarily due to new capital expenditures and program expansions to accommodate a higher volume of students.

Other educational services and facilities expense increased by $0.5 million during the three months ended June 30, 2025, primarily due to higher expenses for training aids and insurance.

Table of Contents

Selling, general and administrative expenses

Selling, general and administrative expenses for the three months ended June 30, 2025 were $84.5 million, as compared to $74.7 million for the three months ended June 30, 2024. This increase was primarily due to costs associated with our business strategies.

The following tables set forth the significant components of our selling, general and administrative expenses by segment (in thousands):


	Three Months Ended June 30, 2025
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	20,457	$	7,142	$	6,337	$	33,936
Bonus expense	2,044		426		1,510		3,980
Stock-based compensation	393		208		1,920		2,521
Compensation and related costs	22,894		7,776		9,767		40,437
Advertising and marketing expense	15,010		7,534		151		22,695
Professional and contract services expense	2,093		668		3,819		6,580
Other selling, general and administrative expenses	10,507		6,413		(2,090)		14,830
Total selling, general and administrative expenses	$	50,504	$	22,391	$	11,647	$	84,542


	Three Months Ended June 30, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	20,010	$	7,066	$	4,045	$	31,121
Bonus expense	3,248		807		2,467		6,522
Stock-based compensation	409		56		1,289		1,754
Compensation and related costs	23,667		7,929		7,801		39,397
Advertising and marketing expense	13,169		6,067		186		19,422
Professional and contract services expense	1,760		1,850		3,054		6,664
Other selling, general and administrative expenses	6,877		3,010		(635)		9,252
Total selling, general and administrative expenses	$	45,473	$	18,856	$	10,406	$	74,735

UTI

Compensation and related costs decreased by $0.8 million for the three months ended June 30, 2025 primarily due to lower bonus expense when compared to the prior year.

Advertising and marketing expense increased year over year by $1.8 million. UTI advertising and marketing expense as a percentage of revenues increased to 11.4% for the three months ended June 30, 2025 as compared to 11.2% in the prior year.

Other selling, general and administrative expenses increased by $3.6 million primarily due to a $2.2 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $1.6 million over the prior year as a result of higher revenues and student volumes.

Concorde

Advertising and marketing increased year over year by $1.5 million. Concorde advertising and marketing expense as a percentage of revenues for the three months ended June 30, 2025 and 2024 was 10.3% and 10.1%, respectively.

Professional and contract services expense decreased by $1.2 million for the three months ended June 30, 2025 primarily due to a reduction of legal and contract service expenses as several of the integration activities were completed in the prior year.

Other selling, general and administrative expenses increased by $3.4 million for the three months ended June 30, 2025 primarily related to an increase in the provision for credit losses of $2.4 million, an increase in software expenses of $0.4

Table of Contents

million, and a $0.3 million increase in human resource expenses. These increases are aligned with higher revenues and higher capital expenditures to support our larger student and employee volumes.

Corporate

Compensation and related costs increased by $2.0 million three months ended June 30, 2025 primarily due to additional headcount hired to support the execution of our business strategies.

Professional fees and contract services increased by $0.8 million for the three months ended June 30, 2025 primarily due to an increase of $0.4 million for legal expenses and other projects to support our business strategies.

Other selling, general and administrative expenses decreased by $1.5 million for the three months ended June 30, 2025. This decrease is primarily due to an increase of $2.5 million in corporate expenses that were allocated to the UTI and Concorde segments compared to the prior period. These corporate expenses included primarily human resource expenses and information technology costs that increased with the overall headcount and operations. The decrease in expenses is partially offset by a $0.7 million increase in software expenses and a $0.3 million increase in employee awards.

Income taxes

Income tax expense for the three months ended June 30, 2025 was $3.7 million, or 25.7% of pre-tax income, compared to $1.8 million, or 26.2% of pre-tax income, for the three months ended June 30, 2024. The effective income tax rate for the three months ended June 30, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three months ended June 30, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.

Results of Operations: Nine Months Ended June 30, 2025 Compared to Nine Months Ended June 30, 2024

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.


	Nine Months Ended June 30,
	2025		2024
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	50.3	%	53.2	%
Selling, general and administrative	40.2	%	40.7	%
Total operating expenses	90.5	%	93.9	%
Income from operations	9.5	%	6.1	%
Interest income	0.9	%	0.9	%
Interest expense	(0.8)	%	(1.3)	%
Other income (expense), net	—	%	0.1	%
Total other income (expense), net	0.1	%	(0.3)	%
Income before income taxes	9.6	%	5.8	%
Income tax expense	(2.4)	%	(1.4)	%
Net income	7.2	%	4.3	%
Preferred stock dividends	—	%	(0.2)	%
Income available for distribution	7.2	%	4.1	%
Income allocated to participating securities	—	%	(0.5)	%
Net income available to common shareholders	7.2	%	3.6	%

Table of Contents

Revenues

The following table presents revenue by segment (in thousands):


	Nine Months Ended June 30, 2025									Nine Months Ended June 30, 2024
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	397,169		$	216,005		$	613,174		$	355,831	$	180,498	$	536,329
Year over Year % Change	11.6		%	19.7		%	14.3		%

Revenues for the nine months ended June 30, 2025 were $613.2 million, an increase of $76.8 million, or 14.3%, as compared to revenues of $536.3 million for the nine months ended June 30, 2024.

UTI

Revenues for UTI for the nine months ended June 30, 2025 were $397.2 million compared to $355.8 million in the prior year period. Revenue increased primarily due to a 13.7% increase in new student starts and a 7.9% increase in average full-time active students from the prior period.

Concorde

Revenues for Concorde for the nine months ended June 30, 2025 were $216.0 million compared to $180.5 million in the prior year period. Revenues increased primarily due to an 16.2% increase in new student starts and a 16.9% increase in average full-time active students from the prior period.

Educational services and facilities expenses

Educational services and facilities expenses were $308.2 million for the nine months ended June 30, 2025, as compared to $285.2 million for the nine months ended June 30, 2024, which was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.

The following table sets forth the significant components of our educational services and facilities expenses by segment (in thousands):


	Nine Months Ended June 30, 2025
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	96,579	$	80,018	$	176,597
Bonus expense	2,411		1,798		4,209
Stock-based compensation	341		—		341
Compensation and related costs	99,331		81,816		181,147
Occupancy costs	23,805		16,819		40,624
Supplies and maintenance and student expense	20,313		12,624		32,937
Depreciation and amortization expense	17,913		4,729		22,642
Contract services expense	3,028		1,764		4,792
Other educational services and facilities expense	17,287		8,804		26,091
Total educational services and facilities expense	$	181,677	$	126,556	$	308,233

Table of Contents


	Nine Months Ended June 30, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	87,697	$	68,954	$	156,651
Bonus expense	2,266		763		3,029
Stock-based compensation	300		—		300
Compensation and related costs	90,263		69,717		159,980
Occupancy costs	22,602		16,531		39,133
Supplies, maintenance and student expense	25,721		12,287		38,008
Depreciation and amortization expense	16,628		3,179		19,807
Contract services expense	2,733		1,530		4,263
Other educational services and facilities expense	17,046		6,937		23,983
Total educational services and facilities expense	$	174,993	$	110,181	$	285,174

UTI

Compensation and related costs increased by $9.1 million for the nine months ended June 30, 2025 primarily due to additional instructors and other campus related personnel hired to support the new programs added and overall growth in the student population.

Occupancy costs increased by $1.2 million for the nine months ended June 30, 2025, primarily due to new lease activity associated with the announced new campus growth and annual rate increases on existing leases.

Supplies, maintenance and student expense decreased by $5.4 million for the nine months ended June 30, 2025 primarily due to a $5.2 million decrease in student housing expenses.

Depreciation and amortization expense increased by $1.3 million for the nine months ended June 30, 2025 primarily due to increased capital expenditures related to the new program launches and expansions.

Concorde

Compensation and related costs increased by $12.1 million for the nine months ended June 30, 2025 primarily due to increased instructors and other campus related personnel hired to support overall growth in the student population and new program expansions.

Depreciation and amortization expense increased by $1.6 million during the nine months ended June 30, 2025, primarily due to new capital expenditures and program expansions to accommodate a higher volume of students.

Other educational services and facilities expense increased by $1.9 million during the nine months ended June 30, 2025, primarily due to higher expenses for training aids and insurance.

Selling, general and administrative expenses

Selling, general and administrative expenses for the nine months ended June 30, 2025 were $246.5 million. This represents an increase of $28.2 million, as compared to $218.3 million for the nine months ended June 30, 2024, which is primarily due to costs associated with our business strategies.

Table of Contents

The following table sets forth the significant components of our selling, general and administrative expenses by segment (in thousands):


	Nine Months Ended June 30, 2025
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	61,183	$	20,026	$	17,378	$	98,587
Bonus expense	8,176		1,579		5,277		15,032
Stock-based compensation	1,138		476		4,447		6,061
Compensation and related costs	70,497		22,081		27,102		119,680
Advertising and marketing expense	44,536		22,791		551		67,878
Professional and Contract services expense	5,876		2,152		11,672		19,700
Other selling, general and administrative expenses	27,821		16,419		(5,040)		39,200
Total selling, general and administrative expenses	$	148,730	$	63,443	$	34,285	$	246,458


	Nine Months Ended June 30, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	58,581	$	20,605	$	11,469	$	90,655
Bonus expense	8,766		2,023		4,617		15,406
Stock-based compensation	1,001		133		4,265		5,399
Compensation and related costs	68,348		22,761		20,351		111,460
Advertising and marketing expense	40,422		19,199		397		60,018
Professional and Contract services expense	5,083		5,449		8,575		19,107
Other selling, general and administrative expenses	19,673		8,818		(790)		27,701
Total selling, general and administrative expenses	$	133,526	$	56,227	$	28,533	$	218,286

UTI

Compensation and related costs increased by $2.1 million for the nine months ended June 30, 2025 primarily due to an increase in headcount to support the new campus and program growth for the UTI segment.

Advertising and marketing expense increased by $4.1 million for the nine months ended June 30, 2025. Advertising and marketing expense as a percentage of revenues decreased to 11.2% for the nine months ended June 30, 2025 as compared to 11.4% in the prior year.

Professional and contract services expenses increased by $0.8 million for the nine months ended June 30, 2025 primarily due to projects to support the new campus and program growth for the UTI segment.

Other selling, general and administrative expenses increased by $8.1 million for the nine months ended June 30, 2025 primarily due to a $5.4 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $2.4 million over the prior year as a result of higher revenue and student volumes.

Concorde

Concorde compensation and related costs decreased by $0.7 million for the nine months ended June 30, 2025 primarily due to continued integration activities and the centralization of more processes within the Corporate division.

Advertising and marketing expense increased by $3.6 million for the nine months ended June 30, 2025. Advertising and marketing expense as a percentage of revenues was 10.6% for both the nine months ended June 30, 2025 and 2024.

Professional and contract services expense decreased by $3.3 million for the nine months ended June 30, 2025 primarily due a decrease of $1.7 million in legal fees and a decrease of $1.6 million in contract services as several of the integration activities were completed in the prior year.

Table of Contents

Other selling, general and administrative expense increased by $7.6 million for the nine months ended June 30, 2025 primarily related to an increase in the provision for credit losses of $5.2 million, an increase in software expenses of $1.2 million, and an increase in allocated corporate expenses related to human resources and information technology expenses of $0.7 million. These increases are aligned with our higher revenues and to support our larger student and employee volumes.

Corporate

Corporate compensation and related costs increased by $6.8 million for the nine months ended June 30, 2025 primarily due to additional headcount hired to support the execution of our business strategies.

Professional and contract services expense increased by $3.1 million for the nine months ended June 30, 2025 primarily due to an increase of $1.7 million for legal expenses and a $1.3 million increase related to professional and contract services for projects that support our business strategies.

Other selling, general and administrative expenses decreased by $4.3 million for the nine months ended June 30, 2025. This decrease is primarily due to an increase of $6.1 million in corporate expenses that were allocated to the UTI and Concorde segments compared to the prior period. These corporate expenses included primarily human resource expenses and information technology expenses that increased with the overall headcount and operations. This decrease is partially offset by a $1.1 million increase in software expenses and a $1.1 million increase in employee-related costs primarily driven by recruitment efforts.

Income taxes

Our income tax expense for the nine months ended June 30, 2025 was $14.5 million, or 24.6% of pre-tax income, compared to $7.7 million, or 24.9% of pre-tax income, for the nine months ended June 30, 2024. The effective income tax rate for the nine months ended June 30, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the nine months ended June 30, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.

Preferred stock dividends

As of December 18, 2023, no shares of the Series A Preferred Stock remained outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.

Pursuant to the Certificate of Designations, we recorded a preferred stock cash dividend of $1.1 million prior to the Series A preferred conversion during the nine months ended June 30, 2024.

Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $44.3 million and $22.1 million for the nine months ended June 30, 2025 and 2024, respectively.

Income allocated to participating securities

Our previously outstanding Series A Preferred Stock was considered a participating security because, in the event that we paid a dividend or made a distribution on the outstanding common stock, we were required to pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. There was no income allocated to participating

Table of Contents

securities for the nine months ended June 30, 2025. The amount of income allocated to the participating securities for the nine months ended June 30, 2024 was $2.9 million.

Net income available to common shareholders

After allocating the income to the participating securities, we had $44.3 million and $19.2 million of net income available to common shareholders for the nine months ended June 30, 2025 and 2024, respectively.

Non-GAAP Financial Measures

Our earnings before interest, income taxes, depreciation and amortization (“EBITDA”) for the three and nine months ended June 30, 2025 were $22.6 million and $83.1 million, respectively, compared to $14.8 million and $54.8 million for the three and nine months ended June 30, 2024. We define EBITDA as net income (loss), before interest (income) expense, income tax expense (benefit), and depreciation and amortization.

EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

EBITDA reconciles to net income, as follows (in thousands):


	Three Months Ended June 30,				Nine Months Ended June 30,
	2025		2024		2025		2024
Net income	$	10,663	$	4,985	$	44,262	$	23,161
Interest income	(1,445)		(1,440)		(4,833)		(4,842)
Interest expense	1,394		2,149		4,724		7,204
Income tax expense	3,689		1,772		14,453		7,699
Depreciation and amortization	8,315		7,376		24,452		21,562
EBITDA	$	22,616	$	14,842	$	83,058	$	54,784

Liquidity and Capital Resources

Overview of Liquidity

Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand, short-term investments, and the Revolving Credit Facility will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced growth, diversification and optimization initiatives throughout the fiscal year and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation and expansion of new programs in existing markets where we continue to optimize utilization of our campus facilities.

Our aggregate cash and cash equivalents were $70.7 million as of June 30, 2025, a decrease of $91.2 million from September 30, 2024 due primarily to cash used to purchase held-to-maturity investments of $54.6 million, and net repayments of $50.0 million to the Revolving Credit Facility. Our available liquidity under the Revolving Credit Facility was $119.0 million as of June 30, 2025.

Strategic Uses of Cash

We believe that uses of our cash resources may include consideration of additional strategic acquisitions and organic growth

Table of Contents

initiatives, the purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, and cash and cash equivalents, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.

Long-term Debt and Letters of Credit

As of June 30, 2025, we had $74.1 million of long-term debt outstanding, which is comprised of two term loans, a finance lease and our Revolving Credit Facility. Of the $74.1 million outstanding, $27.7 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046% over the seven-year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $36.3 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% over the seven-year term, secured in connection with the Lisle, Illinois campus property purchase in February 2022. For each of the term loans, a derivative interest rate swap is in place that fixes the interest rate on 50% of the loan at a market rate at the time the derivative was initiated. Approximately $4.1 million relates to a finance lease for a campus within our Concorde segment. The remaining $6.0 million relates to funds drawn from the $125.0 million Revolving Credit Facility for working capital purposes.

In July 2025, we used cash on hand to repay $6.0 million outstanding on the Revolving Credit Facility. Additionally in July 2025, we issued a letter of credit under the Revolving Credit Facility for $19.6 million, which expires on June 30, 2026, to the ED in order to lift core growth restrictions imposed on Concorde and MIAT campuses as a result of our acquisitions. These two transactions reduced the overall availability under the Revolving Credit Facility to $105.4 million and sub-facility available for letters of credit to $0.4 million.

We are subject to certain customary affirmative and negative covenants under the Revolving Credit Facility and the Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on liens, encumbrances and indebtedness and various financial covenants, including debt service coverage ratios. As of June 30, 2025, we were in compliance with our debt covenants under our Term Loans. Under our Revolving Credit Facility, however, while we were in compliance with the Fixed Charge Coverage and Leverage ratios, our Quick Ratio of 0.62 at June 30, 2025 did not meet the required Quick Ratio of 0.65. The failure of this covenant was primarily due to paying down the Revolving Credit Facility with available cash and additional cash investments in held-to-maturity securities which are excluded from the Quick Ratio calculation. We have obtained a waiver for the failure to meet the quick ratio covenant as of June 30, 2025 from Fifth Third Bank.

See Note 10 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the Revolving Credit Facility.

Dividends

We currently do not pay a cash dividend on our common stock.

Principal Sources of Liquidity

Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans’ benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student’s academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student’s academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through cash payment plans and those under retail installment contracts. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.

Surety Bonds

Each of our campuses must be authorized by the applicable state education agency in which the campus is located to operate and to grant certificates, diplomas or degrees to its students. Our campuses are subject to extensive, ongoing regulation by each of these states. Additionally, our campuses are required to be authorized by the applicable state education agencies of certain other states in which our campuses recruit students. Our insurers issue surety bonds on behalf of our campuses and admissions representatives with multiple states to maintain authorization to conduct our business. We are obligated to

Table of Contents

reimburse our insurers for any surety bonds that are paid by the insurers. As of June 30, 2025, the total face amount of these surety bonds was approximately $28.3 million.

Operating Activities

Our net cash provided by operating activities was $40.2 million for the nine months ended June 30, 2025, compared to $18.4 million for the nine months ended June 30, 2024.

Net income, after adjustments for non-cash items, for the nine months ended June 30, 2025 provided cash of $109.2 million. The non-cash items included $24.5 million for depreciation and amortization expense, $17.5 million for amortization of right-of-use assets for operating leases, $15.1 million for our provision for credit losses, and $6.4 million for stock-based compensation expense.

Changes in operating assets and liabilities used cash of $69.0 million primarily due to the following:

•The change in deferred revenue used cash of $25.5 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at June 30, 2025 as compared to September 30, 2024.

•The change in receivables used cash of $21.9 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

•The change in our operating lease liabilities used cash of $16.8 million primarily as a result of rent payments.

•The change in other assets used cash of $5.4 million and was primarily attributable to the increase in notes receivable related to retail installment contracts.

•The change in prepaid expenses and other current assets used cash of $4.5 million primarily due to the timing of payments.

•The change in notes receivable used cash of $4.1 million primarily due to higher utilization of UTI’s proprietary loan program.

•The change in accounts payable and accrued expenses provided cash of $6.5 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

•The change in income tax payable/receivable provided cash of $3.6 million primarily due to the timing of tax payments.

Net income, after adjustments for non-cash items, for the nine months ended June 30, 2024 provided cash of $70.5 million. The non-cash items included $21.6 million for depreciation and amortization expense, $16.5 million for amortization of right-of-use assets for operating leases, $5.7 million for stock-based compensation expense, and $5.1 million for our provision for credit losses.

Changes in operating assets and liabilities used cash of $52.2 million primarily due to the following:

•The change in deferred revenue used cash of $19.8 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at June 30, 2024 as compared to September 30, 2023.

•Changes in our operating lease liability, primarily as a result of rent payments, used cash of $15.9 million.

•The change in receivables used cash of $9.7 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

•The increase in prepaid expenses used cash of $7.3 million primarily due to the timing of payments.

•The increase in notes receivable used cash of $4.7 million primarily due to higher utilization of UTI’s proprietary loan program.

•The increase in accounts payable and accrued expenses provided cash of $8.6 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

Table of Contents

Investing Activities

During the nine months ended June 30, 2025, cash used in investing activities was $78.3 million, which included the purchase of held-to-maturity investments of $54.6 million and the purchase of property and equipment of $25.5 million to support new campus and program expansions at both UTI and Concorde.

During the nine months ended June 30, 2024, cash used in investing activities was $16.5 million for the purchase of property and equipment, primarily to support new program expansions at both UTI and Concorde.

Financing Activities

During the nine months ended June 30, 2025, cash used in financing activities was $56.0 million which was primarily related to $50.0 million in net payments on the Revolving Credit Facility. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $4.7 million, and payment of term loans and finance leases of $2.0 million, partially offset by $0.7 million related to proceeds of from stock option exercises.

During the nine months ended June 30, 2024, cash used in financing activities was $39.7 million which was primarily related to $23.0 million in net payments on the Revolving Credit Facility, or $59.0 million in payments offset by $36.0 million in proceeds. Additionally, $11.5 million was used to repurchase Series A Preferred Stock. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details on the repurchase. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $2.2 million, the payment of long-term debt of $1.9 million, and the payment of preferred dividends of $1.1 million.

Seasonality and Trends

Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in the total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with GAAP and management’s discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the nine months ended June 30, 2025 from those previously disclosed in Part II, Item 7 of our 2024 Annual Report on Form 10-K.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our market risk exposure during the nine months ended June 30, 2025. For a discussion of our exposure to market risk, refer to Part II Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in our 2024 Annual Report on Form 10-K.

Table of Contents

Item 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.

Table of Contents

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitration, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current and former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we would accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability. Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim. Because we cannot predict with certainty the ultimate resolution of the legal proceedings (including lawsuits, investigations, regulatory proceedings or claims) asserted against us, it is not currently possible to provide such an estimate. The ultimate outcome of pending legal proceedings to which we are a party may have a material adverse effect on our business, cash flows, results of operations or financial condition.

Item 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item 1A of our 2024 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results. Except as set forth below, there have been no material changes to the risk factors disclosed in Part I, Item 1A of our 2024 Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Recent changes by Congress to the laws governing the use of funds received through Title IV Programs could reduce our student population, revenues and/or profit margin.

Congress periodically revises the HEA and other laws, and enacts new laws, governing Title IV Programs and determining the funding level for each Title IV Program. Congress most recently reauthorized the HEA in 2008 and, despite repeated attempts, has not completed a full reauthorization since then. In addition to HEA reauthorization, policies directly related to Title IV Programs and funding for those programs may be impacted by the annual budget and appropriations process as well as by other legislation. In this regard, on July 4, 2025, Congress enacted the One Big Beautiful Bill Act (“OBBBA”). Under the OBBBA, Congress approved amendments to the HEA that, among other things, revised certain Title IV Programs, including provisions that condition the eligibility of educational programs upon compliance with earnings benchmarks that compare former students’ median earnings after completing a program to the median earnings of working adults with lesser credential, and other provisions that will limit or reduce the amount of Title IV Program funding that may be available to some higher education students. The impact of these changes and other changes to the HEA enacted as part of the OBBBA, and of related future regulatory and policy changes, is unknown at this time.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

(a) None.

(b) None.

Table of Contents

(c) During the three months ended June 30, 2025, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Item 6. EXHIBITS

The following exhibits required by Item 601 of Regulation S-K are filed or furnished with this report, as applicable:


Exhibit Number						Description
31.1*						Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*						Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1+						Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2+						Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*						XBRL Instance Document.
101.SCH*						XBRL Taxonomy Extension Schema Document.
101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*						XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document.
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

__________________

* Filed herewith.

+ Furnished herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNIVERSAL TECHNICAL INSTITUTE, INC.

Date:

August 7, 2025

By:

/s/ Bruce Schuman

Name:

Bruce Schuman

Title:

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date:

August 7, 2025

By:

/s/ Christine C.S. Kline

Name:

Christine C.S. Kline

Title:

Vice President and Chief Accounting Officer

(Principal Accounting Officer)

Source:

FAQ

How much did UTI (NYSE:UTI) earn per share in Q3 FY25?

Diluted EPS was $0.19, up from $0.09 in the prior-year quarter.

What drove Universal Technical Institute's 15% revenue increase?

Organic enrollment gains at legacy UTI campuses and a 21% jump at Concorde contributed to the $204.3 m total.

How has UTI's debt position changed since September 2024?

Total debt fell to $73.8 m from $126.1 m, a 41% reduction driven by revolver pay-downs.

Why did cash balances decline sharply this quarter?

Management used cash to repay $56 m on the revolver and purchased $54.6 m of held-to-maturity bonds.

Did Universal Technical Institute meet all loan covenants?

Leverage metrics were met, but the quick-ratio (0.62 vs 0.65) missed; the lender granted a waiver.

AG真人官方

[10-Q] Universal Technical Institute, Inc. Quarterly Earnings Report

Insights

FAQ

How much did UTI (NYSE:UTI) earn per share in Q3 FY25?

What drove Universal Technical Institute's 15% revenue increase?

How has UTI's debt position changed since September 2024?

Why did cash balances decline sharply this quarter?

Did Universal Technical Institute meet all loan covenants?

NYSE:UTI

UTI Rankings

UTI Latest News

UTI Latest SEC Filings

UTI Stock Data

AG真人官方

Trending News

[10-Q] Universal Technical Institute, Inc. Quarterly Earnings Report

Insights

Equity Research Analyst positive

Risk Analyst neutral

FAQ

How much did UTI (NYSE:UTI) earn per share in Q3 FY25?

What drove Universal Technical Institute's 15% revenue increase?

How has UTI's debt position changed since September 2024?

Why did cash balances decline sharply this quarter?

Did Universal Technical Institute meet all loan covenants?

NYSE:UTI

UTI Rankings

UTI Latest News

UTI Latest SEC Filings

UTI Stock Data